What's new

EMEA-003469-PIP01-23

EMEA-003469-PIP01-23

Feb 13, 2025 - 16:45
 0
EMEA-003469-PIP01-23
EMEA-003469-PIP01-23
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Ruxience, rituximab, D...

Next Article

New Jersey residential customers face 20% bill hikes, driven by PJM capacity pri...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Vaxzevria (previously COVID-19 Vaccine AstraZeneca), COVID-19 vaccine (ChAdOx1-S [recombinant]) (AZD1222), decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Vaccines, PIP number: P/0273/2024

Opinion/decision on a Paediatric investigation plan (PI...

Feb 12, 2025  0

Methylphenidate, prolonged-release tablet 18 mg, 27 mg,...

Feb 10, 2025  0

Orphan designation: Overview

Orphan designation: Overview

Feb 28, 2025  0